128 related articles for article (PubMed ID: 2560792)
1. Lead chelates of meso- and racemic-dimercaptosuccinic acid.
Rivera M; Aposhian HV; Fernando Q
J Inorg Biochem; 1989 Dec; 37(4):283-93. PubMed ID: 2560792
[TBL] [Abstract][Full Text] [Related]
2. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
Aposhian HV; Aposhian MM
Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
[TBL] [Abstract][Full Text] [Related]
3. Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid.
Rivera M; Zheng W; Aposhian HV; Fernando Q
Toxicol Appl Pharmacol; 1989 Aug; 100(1):96-106. PubMed ID: 2548305
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and its chelates of lead (II), cadmium(II), and mercury(II).
Rivera M; Levine DJ; Aposhian HV; Fernando Q
Chem Res Toxicol; 1991; 4(1):107-14. PubMed ID: 1655086
[TBL] [Abstract][Full Text] [Related]
5. Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning.
Fang X; Fernando Q
Chem Res Toxicol; 1995 Jun; 8(4):525-36. PubMed ID: 7548732
[TBL] [Abstract][Full Text] [Related]
6. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
Fang X; Hua F; Fernando Q
Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of meso- and rac-2,3-dimercaptosuccinic acids and their zinc complexes in aqueous solution.
Fang X; Fernando Q
Chem Res Toxicol; 1994; 7(6):770-8. PubMed ID: 7696531
[TBL] [Abstract][Full Text] [Related]
8. Conformations of zinc chelates of meso- and rac-2,3-dimercaptosuccinic acid in aqueous solution.
Fang X; Fernando Q
Chem Res Toxicol; 1994; 7(6):882-90. PubMed ID: 7696547
[TBL] [Abstract][Full Text] [Related]
9. The presence of lead decreases the availability of meso-2, 3-dimercaptosuccinic acid for analysis in the monobromobimane assay.
Lever SZ; Parsons TL
Chem Res Toxicol; 1999 Nov; 12(11):1057-65. PubMed ID: 10563831
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure, and properties of rac-2,3-dimercaptosuccinic acid, a potentially useful chelating agent for toxic metals.
Fang X; Fernando Q
Chem Res Toxicol; 1994; 7(2):148-56. PubMed ID: 8199302
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo lead mobilization of meso- and rac-2,3-dimercaptosuccinic acids in albino Wistar rats.
Jones MM; Singh PK; Kostial K; Blanusa M; Piasek M; Restek-Samarozija N
Pharmacol Toxicol; 1997 Apr; 80(4):182-6. PubMed ID: 9140137
[TBL] [Abstract][Full Text] [Related]
12. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230
[TBL] [Abstract][Full Text] [Related]
13. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
[TBL] [Abstract][Full Text] [Related]
14. Mobilisation of cadmium by meso- and racemic-2,3-dimercaptosuccinic acid (DMSA) in rats.
Blanusa M; Kostial K; Restek-Samarzija N; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 2000 Oct; 87(4):179-81. PubMed ID: 11097272
[TBL] [Abstract][Full Text] [Related]
15. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection.
Zhu X; Lever SZ
Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952
[TBL] [Abstract][Full Text] [Related]
16. Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
Maiorino RM; Aposhian HV
Biochem Pharmacol; 1989 Apr; 38(7):1147-54. PubMed ID: 2539817
[TBL] [Abstract][Full Text] [Related]
17. Use of the Caco-2 cell model to assess the relative lead-chelating ability of diasterioisomers of 2,3-dimercaptosuccinic acid.
Pigman EA; Lott JR; Fernando Q; Blanchard J
Environ Health Perspect; 1999 Feb; 107(2):111-5. PubMed ID: 9924005
[TBL] [Abstract][Full Text] [Related]
18. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
Aposhian HV; Maiorino RM; Dart RC; Perry DF
Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
[TBL] [Abstract][Full Text] [Related]
20. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
